GlaxoSmithKline
10,498
$40.739876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$40.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.35 (+0.87%) Today
$0.00 (0.00%) As of 7:43 AM EDT after-hours
Why Robinhood?
You can buy or sell GSK and other stocks, options, ETFs, and crypto commission-free!
About GSK
GlaxoSmithKline plc, also called GlaxoSmithKline, is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). Read More The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Employees
99,437
Headquarters
Middlesex, Greater London
Founded
1999
Market Cap
101.35B
Price-Earnings Ratio
16.86
Dividend Yield
4.86
Average Volume
2.55M
High Today
$40.79
Low Today
$40.38
Open Price
$40.58
Volume
2.25M
52 Week High
$48.25
52 Week Low
$31.43
Collections
GSK News
Financial PostJul 7
Glaxo and Medicago Team Up on Plant-Based Covid Vaccine
(Bloomberg) — GlaxoSmithKline Plc is collaborating on an experimental Covid-19 vaccine with Medicago, a biotechnology company partly owned by tobacco giant Phil
Analyst Ratings
41%
of 22 ratings
Buy
41%
Hold
45%
Sell
14%
GSK Earnings
$0.00
$0.24
$0.49
$0.73
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Available Jul 29
You May Also Like
More GSK News
Financial TimesJul 6
GSK’s anti-HIV drug better at preventing infection, trial finds
A GlaxoSmithKline anti-HIV drug given every two months is significantly better at preventing infection than the current standard of care, an international trial
ReutersJul 5
Britain nears $625 million Sanofi/GSK COVID-19 vaccine deal: report
LONDON (Reuters) - Britain is close to a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of a potential COVID-
New York TimesJul 5
Britain Nears 500 Million Sterling Supply Deal for Sanofi/GSK COVID-19 Vaccine-Sunday Times
LONDON — Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of their potential COV
